Axel Lehrer to Ebola Vaccines
This is a "connection" page, showing publications Axel Lehrer has written about Ebola Vaccines.
Connection Strength
3.108
-
Williams CA, Wong TAS, Ball AH, Lieberman MM, Lehrer AT. Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model. Viruses. 2022 12 14; 14(12).
Score: 0.873
-
Lehrer AT, Chuang E, Namekar M, Williams CA, Wong TAS, Lieberman MM, Granados A, Misamore J, Yalley-Ogunro J, Andersen H, Geisbert JB, Agans KN, Cross RW, Geisbert TW. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses. Front Immunol. 2021; 12:703986.
Score: 0.797
-
Lehrer AT, Wong TS, Lieberman MM, Johns L, Medina L, Feldmann F, Feldmann H, Marzi A. Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge. Vaccine. 2019 11 08; 37(47):6942-6950.
Score: 0.689
-
Lehrer AT, Wong TS, Lieberman MM, Humphreys T, Clements DE, Bakken RR, Hart MK, Pratt WD, Dye JM. Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice. Vaccine. 2018 05 24; 36(22):3090-3100.
Score: 0.583
-
Chisholm CF, Kang TJ, Dong M, Lewis K, Namekar M, Lehrer AT, Randolph TW. Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide. Eur J Pharm Biopharm. 2019 Mar; 136:213-220.
Score: 0.167